The efficacy of mirabegron additional therapy for lower urinary tract symptoms after treatment with α1-adrenergic receptor blocker monotherapy: prospective analysis of elderly men

BACKGROUND: Mirabegron is a β3-adrenoreceptor agonist developed for treatment of overactive bladder (OAB). α1-Adrenergic receptor blockers are effective for lower urinary tract symptoms (LUTS) in male patients. However, the efficacy of mirabegron additional treatment in elderly male patients with pe...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:BMC Urol
Main Authors: Matsuo, Tomohiro, Miyata, Yasuyoshi, Kakoki, Katsura, Yuzuriha, Miki, Asai, Akihiro, Ohba, Kojiro, Sakai, Hideki
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2016
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4966767/
https://ncbi.nlm.nih.gov/pubmed/27473059
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12894-016-0165-3
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki